Aspire-Lakewood vs Incannex Healthcare
ASBP and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASBP and IXHL compare
Incannex Healthcare is the larger company, worth 2.1 times as much as Aspire-Lakewood ($24.7M against $11.8M).
Incannex Healthcare scores higher on the StockData Score (7 against 2 for Aspire-Lakewood), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASBP | IXHL |
|---|---|---|
| Size and price | ||
| Market cap | $11.8M | $24.7M |
| Share price | $8.41 | $1.97 |
| Change, 1 year | 95.9% | −82.4% |
| Beta (5Y) | – | 1.95 |
| Employees | – | 12 |
| StockData Score | ||
| Total score | 2 | 7 (better) |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 121× | – |
| P/B | 1.0× | 0.4× (better) |
| FCF yield | – | −52.1% |
| Profitability | ||
| Gross margin | −25.0% | – |
| Operating margin | −7495% | – |
| Net margin | −11314% | – |
| Return on equity | −1032% | −47.8% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −0.8× | – |
| Current ratio | 7.99 | 48.81 (better) |
| Altman Z-score | −0.05 (better) | −0.62 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −280% |
| Shareholder yield | 0.00% (better) | −280% |
| Ownership | ||
| Held by institutions | – | 3.6% |
| Held by insiders | 1.4% | – |
Go deeper
- ASBP stock overview
- ASBP income statement
- ASBP valuation and score
- IXHL stock overview
- IXHL income statement
- IXHL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.